Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Mol Med (Berl)
2006 Jan 01;841:46-56. doi: 10.1007/s00109-005-0707-8.
Show Gene links
Show Anatomy links
Regulation of cardiac inwardly rectifying potassium current IK1 and Kir2.x channels by endothelin-1.
Kiesecker C
,
Zitron E
,
Scherer D
,
Lueck S
,
Bloehs R
,
Scholz EP
,
Pirot M
,
Kathöfer S
,
Thomas D
,
Kreye VA
,
Kiehn J
,
Borst MM
,
Katus HA
,
Schoels W
,
Karle CA
.
???displayArticle.abstract???
To elucidate the ionic mechanism of endothelin-1 (ET-1)-induced focal ventricular tachyarrhythmias, the regulation of I(K1) and its main molecular correlates, Kir2.1, Kir2.2 and Kir2.3 channels, by ET-1 was investigated. Native I(K1) in human atrial cardiomyocytes was studied with whole-cell patch clamp. Human endothelin receptors were coexpressed with human Kir2.1, Kir2.2 and Kir2.3 channels in Xenopus oocytes. Currents were measured with a two-microelectrode voltage clamp. In human cardiomyocytes, ET-1 induced a marked inhibition of I(K1) that could be suppressed by the protein kinase C (PKC) inhibitor staurosporine. To investigate the molecular mechanisms underlying this regulation, we studied the coupling of ET(A) receptors to homomeric and heteromeric Kir2.1, Kir2.2 and Kir2.3 channels in the Xenopus oocyte expression system. ET(A) receptors coupled functionally to Kir2.2 and Kir2.3 channels but not to Kir2.1 channels. In Kir2.2 channels lacking functional PKC phosphorylation sites, the inhibitory effect was abolished. The inhibition of Kir2.3 currents could be suppressed by the PKC inhibitors staurosporine and chelerythrine. The coupling of ET(A) receptors to heteromeric Kir2.1/Kir2.2 and Kir2.2/Kir2.3 channels resulted in a strong inhibition of currents comparable with the effect observed in Kir2.2 homomers. Surprisingly, in heteromeric Kir2.1/Kir2.3 channels, no effect was observed. ET-1 inhibits human cardiac I(K1) current via a PKC-mediated phosphorylation of Kir2.2 channel subunits and additional regulatory effects on Kir2.3 channels. This mechanism may contribute to the intrinsic arrhythmogenic potential of ET-1.
Becker,
Ventricular arrhythmias induced by endothelin-1 or by acute ischemia: a comparative analysis using three-dimensional mapping.
2000, Pubmed
Becker,
Ventricular arrhythmias induced by endothelin-1 or by acute ischemia: a comparative analysis using three-dimensional mapping.
2000,
Pubmed
Bányász,
Different effects of endothelin-1 on calcium and potassium currents in canine ventricular cells.
2001,
Pubmed
Das,
Protein kinase C isozymes signaling in the heart.
2003,
Pubmed
Dhamoon,
Unique Kir2.x properties determine regional and species differences in the cardiac inward rectifier K+ current.
2004,
Pubmed
Duru,
Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs?
2001,
Pubmed
James,
Effects of endothelin-1 on K(+) currents from rat ventricular myocytes.
2001,
Pubmed
Karle,
Human cardiac inwardly-rectifying K+ channel Kir(2.1b) is inhibited by direct protein kinase C-dependent regulation in human isolated cardiomyocytes and in an expression system.
2002,
Pubmed
,
Xenbase
Lopatin,
Inward rectifiers in the heart: an update on I(K1).
2001,
Pubmed
Magyar,
Effects of endothelin-1 on calcium and potassium currents in undiseased human ventricular myocytes.
2000,
Pubmed
Matsumoto,
Long-term endothelin a receptor blockade inhibits electrical remodeling in cardiomyopathic hamsters.
2002,
Pubmed
McMurray,
Plasma endothelin in chronic heart failure.
1992,
Pubmed
Miake,
Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression.
2003,
Pubmed
Modesti,
Characterization of endothelin-1 receptor subtypes in isolated human cardiomyocytes.
1999,
Pubmed
Molenaar,
Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium.
1993,
Pubmed
Naruse,
Protein kinase C and myocardial biology and function.
2000,
Pubmed
Preisig-Müller,
Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome.
2002,
Pubmed
,
Xenbase
Pucéat,
Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes.
1994,
Pubmed
Robu,
Localization of functional endothelin receptor signaling complexes in cardiac transverse tubules.
2003,
Pubmed
Rockman,
Seven-transmembrane-spanning receptors and heart function.
2002,
Pubmed
Rubanyi,
Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.
1994,
Pubmed
Schram,
Barium block of Kir2 and human cardiac inward rectifier currents: evidence for subunit-heteromeric contribution to native currents.
2003,
Pubmed
,
Xenbase
Sugden,
An overview of endothelin signaling in the cardiac myocyte.
2003,
Pubmed
Tamaoki,
Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase.
1986,
Pubmed
Tristani-Firouzi,
Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome).
2002,
Pubmed
,
Xenbase
Yanagisawa,
A novel potent vasoconstrictor peptide produced by vascular endothelial cells.
1988,
Pubmed
Zaritsky,
The consequences of disrupting cardiac inwardly rectifying K(+) current (I(K1)) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes.
2001,
Pubmed
Zobel,
Molecular dissection of the inward rectifier potassium current (IK1) in rabbit cardiomyocytes: evidence for heteromeric co-assembly of Kir2.1 and Kir2.2.
2003,
Pubmed
